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ILLUSTRATIVE CASE
A 68-year-old man with a history of ulcer 
disease and mild renal insuffi ciency comes 
to your offi ce complaining of severe pain 
in his right foot. You note swelling and 
redness around the base of the big toe 
and diagnose acute gout. Wishing to avoid 
nonsteroidal anti-infl ammatory drugs 
(NSAIDs) and colchicine because of the 
patient’s medical history, you wonder what 
you can safely prescribe for pain relief.
NSAIDs have become the mainstay of treatment for acute gout,3,4 re-placing colchicine—widely used 
for gout pain relief since the early 19th cen-
tury.5 Colchicine fell out of favor because it 
routinely causes diarrhea and requires cau-
tion in patients with renal insuffi ciency.6 
Now, however, there is growing concern 
about the adverse effects of NSAIDs. 
❚  Comorbidities, age,  
mean fewer options 
NSAIDs increase the risk of gastrointes-
tinal (GI) bleeding, especially in the fi rst 
week of use.7 Cyclooxygenase-2 (COX-2) 
inhibitors, considered as effective as 
NSAIDs in treating acute gout pain,8 are 
also associated with GI bleeds.9 In ad-
dition, NSAIDs and COX-2 inhibitors 
increase cardiovascular risks, prompt-
ing the American Heart Association 
to recommend restricted use of both.10 
NSAIDs’ effect on renal function, fl uid 
retention, and interactions with antico-
agulants are additional concerns, because 
gout patients are generally older and of-
ten have comorbid renal and cardiovas-
cular diseases.3,11-13 
Use a short course of oral 
steroids (prednisone 30-40 
mg/d for 5 days) for treatment 
of acute gout when nonste-
roidal anti-infl ammatory drugs 
(NSAIDs) are contraindicated. 
Steroids are also a reasonable 
choice as fi rst-line treatment.1,2
Strength of recommendation 
B: 2 good-quality, randomized controlled trials (RCTs)
Janssens HJ, Janssen M, van de Lisdonk EH, 
van Riel PL, van Weel C. Use of oral prednisolone 
or naproxen for the treatment of gout arthritis: a 
double-blind, randomized equivalence trial. 
Lancet. 2008;371:1854-1860.
Man CY, Cheung IT, Cameron PA, Rainer TH. 
Comparison of oral prednisolone/paracetamol 
and oral indomethacin/paracetamol combination 
therapy in the treatment of acute goutlike arthritis: 
a double-blind, randomized, controlled trial. Ann 
Emerg Med. 2007;49:670-677. 
Practice changer 
Acute gout: Oral steroids 
work as well as NSAIDs 
Prednisone is a safe and effective alternative when 
NSAIDs are contraindicated
Do you routinely 
prescribe prednisone 
(or other oral steroids) 
for acute gout? 
❑  Yes, but only when 
other treatments 
are contraindicated.
❑  Yes, it’s my preferred 
treatment.
❑  No, I have never 
prescribed oral steroids 
for acute gout.
 Go to www.jfponline.com 
and take our Instant Poll!
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PURLs methodology
This study was selected and 
evaluated using FPIN’s Priority 
Updates from the Research 
Literature (PURL) Surveillance 
System methodology. The 
criteria and ﬁ ndings leading to 
the selection of this study as 
a PURL can be accessed at 
www.jfponline.com/purls. 
In the United States, nearly 70% of 
patients who develop acute gout seek 
treatment from primary care physicians.12 
Family physicians need a safe alternative 
to NSAIDs to relieve the severe pain as-
sociated with this condition. Will oral 
corticosteroids fi t the bill?
STUDY SUMMARIES
❚  Oral steroids: A safe 
and effective alternative 
Janssens et al1 conducted a double-blind, 
randomized equivalence trial of 118 pa-
tients to compare the effi cacy of prednis-
olone and naproxen for the treatment of 
monoarticular gout, confi rmed by crystal 
analysis of synovial fl uid. The study was 
conducted in the eastern Netherlands at 
a trial center patients were referred to by 
their family physicians. Those with major 
comorbidities, including a history of GI 
bleed or peptic ulcer, were excluded.  
Participants were randomized to 
receive either prednisolone 35 mg* or 
naproxen 500 mg twice a day, with look-
alike placebo tablets of the alternate 
drug, for 5 days. Pain, the primary out-
come, was scored on a validated visual 
analog scale from 0 mm (no pain) to 100 
mm (worst pain experienced).15 The re-
duction in the pain score at 90 hours was 
similar in both groups. Only a few minor 
side effects were reported in both groups, 
and all completely resolved in 3 weeks. 
The study by Man et al2 was a ran-
domized trial that compared indometha-
cin with oral prednisolone in 90 patients 
presenting to an emergency department in 
Hong Kong. Diagnosis of gout was made 
by clinical impression. Participants in the 
indomethacin group also received an in-
tramuscular (IM) injection of diclofenac 
75 mg, and those in both groups were 
monitored for acetaminophen use as a 
secondary endpoint. 
Pain reduction, the primary endpoint, 
was assessed with a 10-point visual ana-
log score, and was slightly better statisti-
cally in the oral steroid group. The study 
was not designed to evaluate for safety, 
but the authors noted that patients in the 
indomethacin group experienced more 
adverse effects (number needed to harm 
[NNH] for any adverse event: 3; NNH 
for serious events: 6).
 Short-term steroids have few side eﬀ ects 
In both studies, patients receiving oral 
steroids experienced no signifi cant side ef-
fects. This fi nding is consistent with other 
studies that have investigated short-term 
oral steroid use in the treatment of both 
rheumatoid arthritis and asthma.16,17
WHAT’S NEW?
❚  Evidence supports use 
of steroids for acute gout 
In the United States, prednisone is pre-
scribed as treatment for acute gout only 
about 9% of the time.12 These 2 stud-
ies—the fi rst randomized trials compar-
ing oral steroids with NSAIDs, the usual 
gout treatment—may lead to greater use 
of steroids for this painful condition. 
Both studies were well designed and 
conducted in an outpatient (or emer-
gency) setting. Both showed that a short 
course of oral steroids is as effective as 
NSAIDs, and without signifi cant side 
effects. 
Previous studies have compared IM 
steroids with NSAIDs, and IM steroids 
with IM adrenocorticotropic hormone 
(ACTH).18,19 However, these studies were 
not blinded—just one of their method-
ological problems.4 
CAVEATS
❚  Joint aspiration 
is not the norm
In the Janssens study, participants were 
diagnosed with gout after monosodium 
urate crystals were found in joint aspi-
rate.1 This may not be the usual practice 
in primary care settings, where a clinical 
diagnosis of gout is typically made. The 
Although prednisone
is prescribed for 
gout only 9% of 
the time, evidence 
suggests it’s a 
good alternative 
to NSAIDs
* Prednisone is the precursor of prednisolone and is 
activated in the liver. The activity of both drugs is 
comparable, and prednisone and prednisolone can be 
converted milligram to milligram. However, prednisolone 
may be preferred for patients with severe liver disease.14 
(In the United States, prednisolone is available as a 
liquid and prednisone as a tablet.)
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authors indicate that the failure to perform 
joint aspiration will lead to occasional 
cases of septic arthritis being treated with 
oral steroids. We recommend joint aspi-
ration or a referral for such a procedure 
when clinical evidence (eg, fever and leu-
kocytosis) is suggestive of septic arthritis. 
❚  Possible impact 
of acetaminophen
In the study by Man et al, acetamino-
phen was used by both groups as an 
adjunct for pain relief, and the amount 
used was higher (mean 10.3 g vs 6.4 g 
over 14 days) in the oral steroid group. 
It is possible that some of the pain re-
lief experienced by those in the steroid 
group may have been from acetamino-
phen; however, a difference of 4 g over a 
14-day period makes that unlikely. Even 
if additional acetaminophen is required, 
the advantages of oral steroids rather 
than NSAIDs or colchicine for patients 
with contraindications remain. 
Also of note: These trials examined 
short-term treatment of acute gout. These 
fi ndings cannot be extrapolated to the 
treatment of intercurrent gout or chronic 
gouty arthritis, since long-term steroid 
use has severe adverse effects. 
CHALLENGES TO IMPLEMENTATION 
❚ No signiﬁ cant barriers
We found little to prevent physicians 
from adopting this practice changer. Oral 
steroids are readily available and inex-
pensive, and most primary care clinicians 
regularly prescribe them for other condi-
tions. This practice change recommenda-
tion should be readily implemented. ■
The PURLs Surveillance System is supported in part by 
Grant Number UL1RR024999 from the National Center 
For Research Resources, a Clinical Translational Science 
Award to the University of Chicago. The content is solely 
the responsibility of the authors and does not necessar-
ily represent the offi cial views of the National Center For 
Research Resources or the National Institutes of Health. 
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Patients with fever 
and leukocytosis 
—suggestive of 
septic arthritis— 
should undergo 
joint aspiration 
before being treated 
with oral steroids 
for acute gout
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